Mercator Medical Balance Sheet Health
Financial Health criteria checks 4/6
Mercator Medical has a total shareholder equity of PLN917.8M and total debt of PLN62.0K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are PLN1.0B and PLN99.4M respectively.
Key information
0.0068%
Debt to equity ratio
zł62.00k
Debt
| Interest coverage ratio | n/a |
| Cash | zł212.81m |
| Equity | zł917.83m |
| Total liabilities | zł99.43m |
| Total assets | zł1.02b |
Recent financial health updates
No updates
Recent updates
Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations
May 08
Investors Don't See Light At End Of Mercator Medical S.A.'s (WSE:MRC) Tunnel
Jan 08Improved Revenues Required Before Mercator Medical S.A. (WSE:MRC) Stock's 31% Jump Looks Justified
Aug 22Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively
Jun 06Returns At Mercator Medical (WSE:MRC) Are On The Way Up
Sep 23Should You Be Adding Mercator Medical (WSE:MRC) To Your Watchlist Today?
Nov 06Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?
Jul 13Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations
May 19What Kind Of Shareholders Hold The Majority In Mercator Medical S.A.'s (WSE:MRC) Shares?
Dec 23
Financial Position Analysis
Short Term Liabilities: MRC's short term assets (PLN621.1M) exceed its short term liabilities (PLN86.8M).
Long Term Liabilities: MRC's short term assets (PLN621.1M) exceed its long term liabilities (PLN12.6M).
Debt to Equity History and Analysis
Debt Level: MRC has more cash than its total debt.
Reducing Debt: MRC's debt to equity ratio has reduced from 92.3% to 0.01% over the past 5 years.
Debt Coverage: MRC's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if MRC's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/02 14:49 |
| End of Day Share Price | 2025/06/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mercator Medical S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tomasz Rodak | Dom Maklerski Banku Ochrony Srodowiska S.A. |
| Dawid Górzynski | PKO BP Securities |
| Aleksandra Jakubowska | Vestor Dom Maklerski SA |